Oral PrEP for HIV prevention. It works
- PMID: 27482408
- PMCID: PMC4946735
- DOI: 10.1016/S2055-6640(20)30492-1
Oral PrEP for HIV prevention. It works
Abstract
There is an ongoing need for effective methods for prevention of HIV infection. A wide range of tools is needed, in varying social and economic contexts, and against different modes of transmission. Recent advances have concentrated on biomedical approaches to prevention, including the use of antiretroviral therapy (ART) prior to possible exposure to HIV: pre-exposure prophylaxis (PrEP).
Keywords: PROUD; PrEP; Pre-exposure prophylaxis; iPERGAY.
References
-
- UNAIDS. 2014. The Gap Report. Available at www.unaids.org/sites/default/files/media_asset/UNAIDS_Gap_report_en.pdf ( accessed June 2015).
-
- Yin Z, Brown AE, Hughes G et al. . HIV in the United Kingdom 2014 Report: data to end 2013. 2014. Available at www.gov.uk/government/uploads/system/uploads/attachment_data/file/401662... ( accessed June 2015).
-
- Molina J-M, Capitant C, Charrea I et al. . 2015. On demand PrEP with oral TDF-FTC in MSM: results of ANRS Ipergay Trial. Conference on Retroviruses and Opportunistic Infections. February 2015. Seattle, WA, USA. Abstract 23LB.
-
- McCormack S, Dunn D. 2015. Pragmatic open-label randomised trial of preexposure prophylaxis. The PROUD Study. Conference on Retroviruses and Opportunistic Infections. February 2015. Seattle,WA, USA. Abstract 22LB.
LinkOut - more resources
Full Text Sources
Miscellaneous